In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 22 | No |
Popular Name: Pergolide Mesylate Pergolide Mesylate
Find On: PubMed — Wikipedia — Google
CAS Numbers: 66104-22-1 , 66104-23-2 , 66104-23-2, 66104-22-1 , 66104-23-2, 66104-22-1 [pergolide] , [66104-23-2]
(6aR,9R)-9-((Methylthio)methyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
(6aR,9R,10aR)-9-(Methylthiomethyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
(8beta)-8-[(methylsulfanyl)methyl]-6-propylergoline
(8beta)-8-[(methylthio)methyl]-6-propylergoline
66104-22-1; D08339; Pergolide (INN); Permax (TN)
66104-23-2; D00502; Pergolide mesilate (JAN); Pergolide mesylate (USP); Permax (TN)
66104-23-2; Pergolide mesylate; Prestwick_652
8beta-[(Methylthio)methyl]-6-propylergoline methanesulfonate salt
CPD000058504; PERGOLIDE MESYLATE SALT; SAM001247070
CPD000058504; Pergolide mesylate; SAM001247070
Ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)-
INN); Pergolide Mesylate (USAN
Pergolida [INN-Spanish];Pergolide Methanesulfonate;Pergolidum [INN-Latin]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.97 | 11.27 | -39.66 | 2 | 2 | 1 | 20 | 315.506 | 4 | ↓ |
Hi High (pH 8-9.5) | 3.97 | 9.08 | -5.67 | 1 | 2 | 0 | 19 | 314.498 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 5.84e-04 g/l | DrugBank-withdrawn |
mechanism | Agonist at the dopamine D2, D1 and serotonin 5-HT(1A), 5-HT(1B), 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptors | IBScreen Bioactives |
biological_use | Also used for veterinary purposes. | IBScreen Bioactives |
Target | Dopamine Receptor | Selleck Chemicals |
therap | dopamine receptor agonist | MicroSource Spectrum |
Therapy | Dopamine receptor agonist; antiparkinsonian | SMDC Iconix |
PUBCHEM_PATENT_ID | EP0026671A1; EP0185491A1; EP0314387A1; EP0314387B1; US4166182; US4180582; US4202979; US4246265; US4675322; US4683313; US4782152; US4797405; US4801712; US5114948; US5416090; WO2000044748A1 | IBM Patent Data |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 101757; 1 methanesulfonic acid | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 101757; SALT: 1 methanesulfonic acid | NIH Clinical Collection via PubChem |
biological_use | Used to treat various conditions including Parkinson's disease, hyperprolactinemia, and restless leg syndrome. | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 50 | 0.46 | Binding ≤ 10μM |
DRD3-1-E | Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 70 | 0.46 | Binding ≤ 10μM |
DRD4-3-E | Dopamine D4 Receptor (cluster #3 Of 4), Eukaryotic | Eukaryotes | 70 | 0.46 | Binding ≤ 10μM |
DRD5-1-E | Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 70 | 0.46 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 7943 | 0.32 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 0 | 0.00 | Functional ≤ 10μM |
DRD2-23-E | Dopamine D2 Receptor (cluster #23 Of 24), Eukaryotic | Eukaryotes | 70 | 0.46 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 70 | 0.46 | Binding ≤ 1μM |
DRD1_BOVIN | Q95136 | Dopamine D1 Receptor, Bovin | 50 | 0.46 | Binding ≤ 1μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 70 | 0.46 | Binding ≤ 1μM |
DRD2_BOVIN | P20288 | Dopamine D2 Receptor, Bovin | 50 | 0.46 | Binding ≤ 1μM |
DRD3_RAT | P19020 | Dopamine D3 Receptor, Rat | 70 | 0.46 | Binding ≤ 1μM |
DRD4_RAT | P30729 | Dopamine D4 Receptor, Rat | 70 | 0.46 | Binding ≤ 1μM |
DRD5_RAT | P25115 | Dopamine D5 Receptor, Rat | 70 | 0.46 | Binding ≤ 1μM |
DRD1_BOVIN | Q95136 | Dopamine D1 Receptor, Bovin | 50 | 0.46 | Binding ≤ 10μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 70 | 0.46 | Binding ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 70 | 0.46 | Binding ≤ 10μM |
DRD2_BOVIN | P20288 | Dopamine D2 Receptor, Bovin | 50 | 0.46 | Binding ≤ 10μM |
DRD3_RAT | P19020 | Dopamine D3 Receptor, Rat | 70 | 0.46 | Binding ≤ 10μM |
DRD4_RAT | P30729 | Dopamine D4 Receptor, Rat | 70 | 0.46 | Binding ≤ 10μM |
DRD5_RAT | P25115 | Dopamine D5 Receptor, Rat | 70 | 0.46 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 3981.07171 | 0.34 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 0.1 | 0.64 | Functional ≤ 10μM |
Description | Species |
---|---|
Dopamine receptors | |
G alpha (i) signalling events | |
G alpha (s) signalling events |